Association of cardiovascular-kidney-metabolic syndrome with postoperative major adverse cardiovascular and cerebrovascular events after non-cardiac surgery

The Cardiovascular-Kidney-Metabolic (CKM) syndrome is highly prevalent among Chinese adults (over 80%), yet its specific association with postoperative outcomes in patients undergoing non-cardiac surgery has not been fully elucidated. This study aimed to evaluate the association between CKM stages and the risk of 30-day major adverse cardiac and cerebrovascular events (MACCE) after non-cardiac surgery, and to identify the specific stage at which risk increases significantly. This single-center retrospective cohort study was conducted at the Second Affiliated Hospital of Army Medical University in Chongqing, China, including 178,232 adult patients aged 18 to 79 years who underwent non-cardiac surgery between July 1, 2016, and June 30, 2025. CKM Stages 0–4 were defined according to the 2023 American Heart Association scientific statement. The primary outcome was 30-day postoperative MACCE, a composite of all-cause mortality, non-fatal myocardial infarction, stroke, major arrhythmia, angina, pulmonary embolism, heart failure, or cardiac arrest. Multivariable logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among the 178,232 patients (median age, 52 years; 55.3% female), 88.8% were at CKM Stage ≥ 1. The overall incidence of postoperative MACCE was 4.3%, which increased stepwise across CKM stages from 1.5% in Stage 0 to 15.9% in Stage 4. After full adjustment for demographics, surgical factors, and comorbidities, the aORs (95% CIs) for MACCE compared with Stage 0 were 1.11 (0.96–1.30, P > 0.05) for Stage 1, 1.41 (1.25–1.60, P < 0.001) for Stage 2, 2.19 (1.90–2.53, P < 0.001) for Stage 3, and 2.91 (2.55–3.34, P < 0.001) for Stage 4. Subgroup analysis showed that men had a higher MACCE risk than women at Stages 0–2, but no significant sex difference was observed at Stages 3–4 (interaction P = 0.68 for Stage 3; P = 0.23 for Stage 4). Sensitivity analyses yielded consistent results. Higher CKM stages were independently associated with a stepwise increase in the risk of 30-day postoperative MACCE, with the risk becoming statistically significant at Stage 2. Whether this association should be used to guide perioperative management requires confirmation in prospective studies. While men exhibited a higher risk than women in Stages 0–2, the risk was similar between sexes in CKM Stages 3–4. Question. What is the association between Cardiovascular-Kidney-Metabolic syndrome stages and the risk of major adverse cardiovascular and cerebrovascular events (MACCE) after non-cardiac surgery? Findings. In this retrospective cohort study of 178,232 Chinese patients, higher CKM stage was an independent, graded risk factor for postoperative MACCE, and Stage 2 was the earliest stage associated with a statistically significant increase in postoperative MACCE risk. Men had a higher risk than women at stages 0–2, a difference that was not observed at stages 3–4. Meaning The findings support considering CKM stages into preoperative risk assessment to inform patient stratification and perioperative management.

Authors

Institutions

Publication Details

Journal
Journal of Anesthesia Analgesia and Critical Care
Published
2026-11-12
DOI
https://doi.org/10.1186/s44158-026-00474-9
Primary Topic
Cardiac, Anesthesia and Surgical Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of cardiovascular-kidney-metabolic syndrome with postoperative major adverse cardiovascular and cerebrovascular events after non-cardiac surgery

Hao Gui-qiang, Hong Li, Yi-Kai Liu, Wan-Qiu Fan et al.
Journal of Anesthesia Analgesia and Critical Care
Cardiac, Anesthesia and Surgical Outcomes
article

Association of cardiovascular-kidney-metabolic syndrome with postoperative major adverse cardiovascular and cerebrovascular events after non-cardiac surgery

Hao Gui-qiang, Hong Li, Yi-Kai Liu, Wan-Qiu Fan, Jun-Yan Lai, Chun-Yu Yu, Fu-Hai Bai
article en

Abstract

The Cardiovascular-Kidney-Metabolic (CKM) syndrome is highly prevalent among Chinese adults (over 80%), yet its specific association with postoperative outcomes in patients undergoing non-cardiac surgery has not been fully elucidated. This study aimed to evaluate the association between CKM stages and the risk of 30-day major adverse cardiac and cerebrovascular events (MACCE) after non-cardiac surgery, and to identify the specific stage at which risk increases significantly. This single-center retrospective cohort study was conducted at the Second Affiliated Hospital of Army Medical University in Chongqing, China, including 178,232 adult patients aged 18 to 79 years who underwent non-cardiac surgery between July 1, 2016, and June 30, 2025. CKM Stages 0–4 were defined according to the 2023 American Heart Association scientific statement. The primary outcome was 30-day postoperative MACCE, a composite of all-cause mortality, non-fatal myocardial infarction, stroke, major arrhythmia, angina, pulmonary embolism, heart failure, or cardiac arrest. Multivariable logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among the 178,232 patients (median age, 52 years; 55.3% female), 88.8% were at CKM Stage ≥ 1. The overall incidence of postoperative MACCE was 4.3%, which increased stepwise across CKM stages from 1.5% in Stage 0 to 15.9% in Stage 4. After full adjustment for demographics, surgical factors, and comorbidities, the aORs (95% CIs) for MACCE compared with Stage 0 were 1.11 (0.96–1.30, P > 0.05) for Stage 1, 1.41 (1.25–1.60, P < 0.001) for Stage 2, 2.19 (1.90–2.53, P < 0.001) for Stage 3, and 2.91 (2.55–3.34, P < 0.001) for Stage 4. Subgroup analysis showed that men had a higher MACCE risk than women at Stages 0–2, but no significant sex difference was observed at Stages 3–4 (interaction P = 0.68 for Stage 3; P = 0.23 for Stage 4). Sensitivity analyses yielded consistent results. Higher CKM stages were independently associated with a stepwise increase in the risk of 30-day postoperative MACCE, with the risk becoming statistically significant at Stage 2. Whether this association should be used to guide perioperative management requires confirmation in prospective studies. While men exhibited a higher risk than women in Stages 0–2, the risk was similar between sexes in CKM Stages 3–4. Question. What is the association between Cardiovascular-Kidney-Metabolic syndrome stages and the risk of major adverse cardiovascular and cerebrovascular events (MACCE) after non-cardiac surgery? Findings. In this retrospective cohort study of 178,232 Chinese patients, higher CKM stage was an independent, graded risk factor for postoperative MACCE, and Stage 2 was the earliest stage associated with a statistically significant increase in postoperative MACCE risk. Men had a higher risk than women at stages 0–2, a difference that was not observed at stages 3–4. Meaning The findings support considering CKM stages into preoperative risk assessment to inform patient stratification and perioperative management.

Journal of Anesthesia Analgesia and Critical Care
Army Medical University (CN), UNSW Sydney (AU)
Good health and well-being
Cardiac, Anesthesia and Surgical Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon